HomeNews

News

Understanding the Intricacies of CAR-T Cell Remedy and Care in Hematologic Malignancies

CAR-T Cell Remedy in Hematologic MalignanciesOn the 2024 American Society of Hematology Annual Assembly, Dr. Sattva S. Neelapu sat down with CURE® to...

Cisplatin-Primarily based Chemo Routine Might Enhance Survival in Bladder Most cancers

Neoadjuvant cisplatin-based chemotherapy exhibits promise in bettering survival and decreasing surgical procedure for muscle-invasive bladder most cancers.Remedy with cisplatin-based neoadjuvant chemotherapy (NAC) and...

Remembering the Classes of a Most cancers Prognosis

Rachel’s first most cancers prognosis was for early-stage DCIS breast most cancers in 2005. Her second prognosis came visiting a decade later for...

Veliparib and Temozolomide Combo Does Not Considerably Prolong Survival for Sufferers With Glioma

Veliparib plus temozolomide doesn't considerably prolong total survival in sufferers with glioma.Including the PARP inhibitor veliparib to remedy with temozolomide didn't considerably prolong...

Placing an Emphasis on Affected person Collaboration in MPN Remedy

Dr. Richard “Rick" Winneker mentioned recommendation that he would offer to sufferers confronted with a myeloproliferative neoplasm (MPN) analysis, placing an emphasis in...

Hot Topics